Dudediligence.

Achieve Life Sciences, Inc

ACHVNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Price
FilingsNewest: 8-K, Director or officer changeOct 1 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: TRAW, SNTI, WVE→

From the filings

Figures

Net income
−$114.0Mlast 12 months
Operating cash flow
−$45.3Mlast 12 months
Cash and equivalents
$48.0Mat the last balance sheet
Shares outstanding
102.7M shareson issue
Every year and quarter →